Molecular profiling: moving away from tumor philately
- PMID: 20811040
- DOI: 10.1126/scitranslmed.3001329
Molecular profiling: moving away from tumor philately
Abstract
Despite the remarkable enhancements in breast cancer classification and characterization, an exhaustive comprehension of the underlying carcinogenic processes and an accurate prediction of its clinical behavior are yet to be achieved. On the wave of recent scientific advances and clinical findings, new cutting-edge technologies are poised to deliver an array of diverse molecular data that are expected to dramatically alter breast cancer diagnosis and treatment.
Similar articles
-
Mixture classification model based on clinical markers for breast cancer prognosis.Artif Intell Med. 2010 Feb-Mar;48(2-3):129-37. doi: 10.1016/j.artmed.2009.07.008. Epub 2009 Dec 14. Artif Intell Med. 2010. PMID: 20005686
-
Application of molecular findings to the diagnosis and management of breast disease: recent advances and challenges.Hum Pathol. 2011 Feb;42(2):153-65. doi: 10.1016/j.humpath.2010.07.008. Epub 2010 Nov 24. Hum Pathol. 2011. PMID: 21106225
-
Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?Int J Surg Pathol. 2009 Aug;17(4):285-302. doi: 10.1177/1066896908328577. Epub 2008 Dec 22. Int J Surg Pathol. 2009. PMID: 19103611 Review.
-
Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.Expert Rev Mol Diagn. 2007 May;7(3):269-80. doi: 10.1586/14737159.7.3.269. Expert Rev Mol Diagn. 2007. PMID: 17489734 Review.
-
[Breast cancer and molecular markers].Gan To Kagaku Ryoho. 2008 Aug;35(8):1261-8. Gan To Kagaku Ryoho. 2008. PMID: 18701834 Review. Japanese.
Cited by
-
Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival.Breast Cancer Res Treat. 2012 Jul;134(1):393-400. doi: 10.1007/s10549-012-2058-9. Epub 2012 Apr 12. Breast Cancer Res Treat. 2012. PMID: 22527105 Free PMC article.
-
Immunotherapy in breast cancer.J Carcinog. 2019 May 23;18:2. doi: 10.4103/jcar.JCar_2_19. eCollection 2019. J Carcinog. 2019. PMID: 31160888 Free PMC article. Review.
-
RNA-Seq-Based Breast Cancer Subtypes Classification Using Machine Learning Approaches.Comput Intell Neurosci. 2020 Oct 29;2020:4737969. doi: 10.1155/2020/4737969. eCollection 2020. Comput Intell Neurosci. 2020. PMID: 33178256 Free PMC article.
-
Emerging Molecular Technology in Cancer Testing.EJIFCC. 2024 Oct 30;35(3):142-153. eCollection 2024 Oct. EJIFCC. 2024. PMID: 39507577 Free PMC article. Review. No abstract available.
-
Opposing effects of Runx2 and estradiol on breast cancer cell proliferation: in vitro identification of reciprocally regulated gene signature related to clinical letrozole responsiveness.Clin Cancer Res. 2012 Feb 1;18(3):901-11. doi: 10.1158/1078-0432.CCR-11-1530. Epub 2011 Dec 6. Clin Cancer Res. 2012. PMID: 22147940 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical